In order to offer a high quantity of quality laboratory equipment that has been used, we needed to assemble a core management team that not only understood the equipment, but how to track it, evaluate it and manage an ever-changing inventory. To that end, every BioSurplus core team member has at least 18 years of skilled experience — with in-depth experience that includes operations, scientific instrumentation, biotech, high-tech, and software architecture and development.
Preston “Cinco” Plumb, President and CEO
Cinco, as he is known, is in charge of the vision and direction for BioSurplus. His 20+ years of experience include serving for three years as Vice President of Corporate Development for TechnoCom, a venture-backed wireless location software and service company. At TechnoCom, Cinco was responsible for creating and managing key strategic relationships and joint ventures and overseeing high profile business and corporate strategy initiatives.
Prior to TechnoCom, he served as Vice President of Business Development for EduPoint, an eLearning Internet marketplace provider. At EduPoint, he was credited with forging several key strategic relationships with Hewlett Packard, KPMG Consulting, Deloitte & Touche, and Microsoft. Cinco has also served as a founding member of Hamilton Ventures, now a multimillion-dollar venture fund; served as CFO and Vice President of Business Development for AccuCom Wireless Services, an early network-based wireless location services and technology provider; and held management positions at ORINCON and Coopers & Lybrand.
Cinco has also advised numerous early stage biotech, high-tech, and traditional companies through his active involvement in UCSD CONNECT and his own consulting practice. He obtained his B.S. in Industrial Engineering Operations Research from the University of California, Berkeley in 1988.
Kathy Scott, Chief Financial Officer
Kathy joined BioSurplus in March 2010. Prior to BioSurplus, Kathy was a Partner at RA Capital Advisors, a San Diego private investment bank providing financial advisory services. She spent over 15 years with RA Capital Advisors, completing billions of dollars of mergers, acquisitions, divestitures, and restructurings for a broad range of corporate clients, both in the United States and internationally.
Kathy managed highly complex transactions, including the acquisition of the Titan Corporation by L-3, and acting as financial advisor to the post-bankruptcy Enron. She has consummated transactions in various industries, including life sciences, energy, aerospace and defense, manufacturing and retail. In addition to leading transactions, she was also the CFO and Chief Compliance Officer at RA Capital.
Kathy started her career as an auditor in Arthur Andersen’s San Diego office, focusing on both public and private clients. She also has been the CFO of FeRx, a start up biotech company. A CPA and CFA charter holder, Kathy graduated magna cum laude from UCLA with a bachelor’s degree in economics / business and was named to membership in Phi Beta Kappa. She is currently a Vice Chair on the board of directors of the YMCA of San Diego County.
Fred Hill, Senior Vice President
Fred is responsible for managing the capital equipment sales team as well as BioSurplus’ auction services division. He has more than 20 years of laboratory, purchasing, marketing, and business development experience in the biotechnology industry. Previously, he was the Principal of Kymeric Consulting, a biotechnology marketing and business development firm. Prior to Kymeric Consulting, Fred was director of marketing and commercial development at Inovio Biomedical Corporation, where he helped commercialize novel oncology and gene therapy technologies.
During his tenure at Teva Pharmaceuticals, he was involved with the strategic aspects of commercializing for more than 30 small-volume parenterals. At Gensia Inc., Fred started as one of the first employees, heading up Analytical Chemistry and eventually transitioning into purchasing and contract negotiations. Prior to Gensia, he held a variety of laboratory positions including working for Nobel Laureate Dr. Roger Guillemin at the Salk Institute.
Fred has also served as vice president of technology for the Medical Marketing Association and as a Director of the San Diego Chapter of the National Association of Purchasing Managers. He obtained his M.S. in Chemistry from the University of California, San Diego, and his M.B.A. from San Diego State University.
Arlen Greer, Chief Technology Officer
Arlen is responsible for systems architecture, software development and IT for BioSurplus. He has held key roles as both an owner and a lead software engineer for the past 18 years in companies such as AptBiz, ToyData Technologies, WebCard, Edupoint, iDriveonline and AutoBytel. Arlen has held CTO positions for the past fifteen years and has helped to take three companies from their initial start-up phase to mezzanine-level, self-sustaining, revenue-generating enterprises. His last start-up, iDriveonline, was acquired by a larger company and went on to consistently perform as one of their most successful divisions for years. Arlen received his computer science training at Rice University in Houston, TX.
Anggie Becorest, Vice President, Software & Analytics
With over 20 years of laboratory, operations, and management experience in the biotech industry, Anggie has held several key positions in R&D, Process Development, and GMP Manufacturing.
Prior to BioSurplus Anggie was Director of Research Operations for Neose Technologies where she was responsible for managing the operations of an R&D and process/scale-up facility. Anggie also held several management and scientific positions at Nextran Inc. (a division of Baxter Healthcare) and Cytel Corporation overseeing protein expression and purification. She was also responsible for the GMP production of Phase I and Phase II protein components for both Nextran and Cytel.
Anggie brings an extensive laboratory and scientific background to BioSurplus including work at The Scripps Research Institute under one of the founders of TSRI, Dr. William Weigle. She obtained her B.S. in Cell Biology and Biochemistry from the University of California, San Diego.
Octavio Espinosa, Vice President, Inside Sales & Marketing Operations
Octavio leads the inside sales, operations and product marketing teams at BioSurplus. Prior to joining the company, he was a biotechnology industry scientist for nearly 25 years and held numerous senior-level positions in the areas of R&D, manufacturing, marketing and customer relations. The core of his technical career was as Senior Microbiologist with the Dow Chemical Company, where he headed bioprocessing and scale-up operations, QC analytical capabilities and technology transfer collaborations.
Prior to Dow, Octavio contributed to the development of Mycogen Corporation, and was instrumental in equipment asset disposition upon its acquisition. Octavio received his marketing and undergraduate microbiology education and training at the University of California, San Diego. He is a member of American Society of Microbiology (ASM), Society of Industrial Microbiology (SIM) and the International Society of Pharmaceutical Engineers (ISPE).
Preston Plumb, Vice President, Service & Repair
Preston is responsible for all aspects of business strategy and management of BioSurplus’ lab equipment service and repair division. He began his career at accountancy firm Arthur Young & Co.; his next position was as Vice President of Finance at medical device company Ivac Corporation, which was sold to Eli Lilly during his tenure.
Preston later founded and served as CEO of medical device company Timron Instruments, eventually merging the company with VitalMetrics Inc. He rose to the level of Chairman and CEO of the combined companies, whose assets were acquired in a multi-million dollar deal by CR Bard and American Cyanamid.